Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Arrowhead Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Arrowhead Pharmaceuticals Inc.
Rating: 1.610791625
Author: Trendlyne DVM scores

Momentum Trap

about

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies desi...

72.81 1.43 (2.00%)

409.16% Gain from 52W Low

666.9K

XNAS Volume

XNAS 17 Jul, 2026 12:40 PM (EDT)

Low Financial Strength

33.3 / 100

Expensive Valuation

10.7 / 100

Technically Neutral

51.5 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 25%

12 analysts

Arrowhead Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies desi...

409.16% Gain from 52W Low

SWOT Analysis

Arrowhead Pharma Inc Live Price Chart

Arrowhead Pharma Inc Live Price Chart